Regeneron’s chief scientist on Trump’s drug pricing policy, gene therapy, and the problem with AI The longtime biotech executive is, as usual, outspoken

https://www.statnews.com/2026/01/15/regeneron-george-yancopoulos-jpm-biotech/ By Matthew HerperJan. 15, 2026 Senior Writer, Medicine, Editorial Director of Events